Digital medicine for infectious diseases.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41730910.
- Also identified by DOI 10.1038/s41467-026-69871-6 and PMC identifier 12929603.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Digital technologies are transforming infectious disease care, from AI-driven drug discovery and diagnostics to telemedicine, wearables, and adherence tools. These innovations promise faster and more equitable responses, bridging geographical and socioeconomic gaps, but raise challenges around bias, privacy, and access. This cross-journal Collection, a collaboration of <i>Nature Communications</i>, <i>Nature Medicine</i>, <i>npj Digital Medicine</i>, <i>Communications Health</i> and <i>Communications Medicine</i>, invites research on digital medicine solutions and best practices for infectious diseases to ensure safe, inclusive, and impactful implementation, as outlined in the Collection scope.